Ebola virus DNA vaccine
Latest Information Update: 30 Apr 2002
Price :
$50 *
At a glance
- Originator Nonindustrial source
- Class Gene therapies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ebola virus infections
Most Recent Events
- 19 Feb 1998 New profile
- 19 Feb 1998 Preclinical development for Ebola virus infections in USA (IM)